glp 1 adoption New Demand in an Old Market GLP-1s in 2025: Who's Using
Description
Short-acting but not long-acting glucagon-like protein-1 receptor agonists are associated with increased development of GERD and Barretts esophagus: results from a global healthcare database
Injecting cold semaglutide directly from the refrigerator is safe and does not reduce efficacy
Given his obesity, a GLP-1 receptor agonist can help with weight loss and lower his risk for hypoglycemia
doi: 10.1210/en.2018-00399
[Google Scholar] 112.Xu Y, et al
